comparemela.com

Latest Breaking News On - Brazilian health regulatory agency - Page 4 : comparemela.com

Completion of PIC/S Participating Authorities' Audits of Kexing Biopharm's Licensed Product Infliximab for Injection

Completion of PIC/S Participating Authorities' Audits of Kexing Biopharm's Licensed Product Infliximab for Injection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
China
Brazil
Indonesia
Chinese
Indonesian
Kexing-biopharm
Haiyan-zheng
Kexing-biopharm-co-ltd
Pics-participating-authority
Brazilian-health-regulatory-agency

Avicanna Reports Full Year 2023 Audited Financial Results

$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022TORONTO, A.

Canada
Toronto
Ontario
Brazil
Colombia
Santa-marta
Magdalena
United-states
American
Colombian
Canadian
El-instituto-nacional

Urgency of Taxing Ultra-Processed Foods in Brazil

Urgency of Taxing Ultra-Processed Foods in Brazil
newsclick.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsclick.in Daily Mail and Mail on Sunday newspapers.

Mexico
Brazil
France
Brazilian
Arthur-chioro
Gonzalo-vecina
Carlos-monteiro
School-of-public-health-the-university
Health-nupens
Epidemiological-research-in-nutrition
National-congress
Ministry-of-health

MediPharm Labs Reports Fourth Quarter and Full Year Results

MediPharm Labs Reports Fourth Quarter and Full Year Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Germany
Canada
Toronto
Ontario
Australia
Brazil
Canadian
America
German
Brazilian
Australian

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%

Medartis Holding AG / Key word: Annual Results Medartis increases sales by 21% and improves its underlying EBITDA margin to 16% 12-March-2024 / 06:30 CET/CEST Release of an ad hoc.

Switzerland
Australia
France
Spain
Tarchamps
Rhôalpes
Mexico
Warsaw
L67
Poland
London
City-of

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.